B2M and neoplasm: The human leukocyte antigen (HLA) system, specifically MHC class I, is encoded by the HLA-A, -B, and -C genes, as well as by beta 2-microglobulin (B2M), and plays a central role in the tumor mechanisms of evading the patient’s immune system [47,48].